CKLSF

Aug 11, 2026, 09:44 UTC

CK Life Sciences International reported interim results for the six months ended June 2026, with revenue of HK$2.716 billion, up 4.2% year-on-year, and a narrowed net loss of HK$28.73 million, compared with a loss of HK$151 million in the same period last year.